Evolus EOLS 深 滬
等待開盤 06-25 09:30:00 美东时间
6.97
+0.230
+3.41%
華盛通- 最 高7.15
- 今 開6.83
- 成交量 60.31万股
- 最 低 6.83
- 昨 收 6.74
- 總市值 4.59亿
- 52周最高 10.20
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.86
- 委 比 8.67%
- 總股本 6585.48万
- 歷史最高 39.50
- 量 比 0.78
- 振 幅 4.75%
- 歷史最低 2.85
- 每 手 1
- 風險率 1.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
BTIG Reiterates Buy on Evolus, Maintains $13 Price Target
BTIG analyst Sam Eiber reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $13 price target.
06-17 18:04
Evolus Shareholders Elect Directors and Ratify Key Proposals
Evolus ( ($EOLS) ) has provided an announcement. At its Annual Meeting of Stock...
06-13 06:14
Evolus Files Prospectus To Offer Up To $250M Of Securities
https://www.sec.gov/Archives/edgar/data/1570562/000157056226000071/evoluss-32026.htm
06-06 04:51
Shares of pharmaceutical companies are trading higher as investors rotate out of chips stocks and move into non-tech industries.
Shares of pharmaceutical companies are trading higher as investors rotate out o...
06-05 02:13
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
AEON Biopharma announced the presentation of new data at the 68th Annual Scientific Meeting of the American Headache Society, demonstrating the biosimilarity of ABP-450 to BOTOX®. The data includes structural and functional comparability through LC-MS peptide mapping and LD50 potency assays, showing high similarity. ABP-450 is a biosimilar candidate for full U.S. market entry, targeting the $3 billion therapeutic neurotoxin market.
06-04 11:00
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
Issued on behalf of Conexeu Sciences Inc. Companies mentioned: Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bi...
05-22 22:31
Evolus shares are trading higher after the company reported better-than-expected Q1 sales results.
Evolus shares are trading higher after the company reported better-than-expecte...
05-05 23:02
Evolus Earnings Call Highlights Profitable Growth Path
Evolus, Inc. (($EOLS)) has held its Q1 earnings call. Read on for the main high...
05-05 08:26
Evolus Ends ATM Facility After Strong Q1 Momentum
Evolus ( ($EOLS) ) has shared an update. Evolus terminated its unused at‑the‑ma...
05-05 04:55
